Alternative oncogene arrangements may occur [6-8], but the extent to which these arrangements contribute to NUT carcinoma pathogenesis remains uncertain and is less well understood compared to the BRD4-NUTM1 fusion. This evidence concerns the gene NUTM1 and nut midline carcinoma.